SAID NGO: Driving Awareness and Action Against Colorectal Cancer in Lebanon
SAID NGO continues to lead the fight against colorectal cancer in Lebanon through impactful awareness campaigns, free screening initiatives, and st...
Young Onset Cancer Team at Trinity St James’s Cancer Institute Hosts Inspiring Patient Event
On the 25th July, the Young Onset Cancer Team at Trinity St James’s Cancer Institute (TSJCI) welcomed over 50 patients, family members, and suppo...
IGET Celebrates Five Years of Advancing Gastrointestinal Cancer Care in Croatia
On 29 November 2025, the Institute for Gastroenterological Tumours (IGET), Zagreb, Croatia, will celebrate its fifth anniversary during Gastric Can...
Progress in Pancreatic Cancer: Highlights from ESMO 2025
New data from ESMO 2025 bring fresh hope in pancreatic cancer treatment, featuring advances in KRAS G12D-targeted therapy (GFH375), antibody–drug...
Progress in Liver and Bile Duct Cancer: New Insights from ESMO 2025
This year’s ESMO Congress showcased key advances in the treatment of liver and bile duct cancers. While some new immunotherapy combinations did n...
Advancing Patient-Centred Care at UEG Week 2025
UEG Week 2025 in Berlin provided a valuable chance to deepen collaboration with healthcare professionals, researchers, and patient advocates. The f...
EU HTA Has Begun: What New Joint Clinical Assessments Mean for Access to Digestive Cancer Medicines
From 12 January 2025, new oncology medicines will undergo EU-wide Joint Clinical Assessments (JCAs). This coordinated evaluation aims to accelerate...
Personalised Progress in Gastric Cancer: Highlights from ESMO 2025
This year at ESMO, new research revealed improved methods to personalise treatment for gastric cancer. These approaches could help patients achieve...
Key Takeaways from ESMO GI 2025 on Pancreatic Cancer
Promising new therapies are emerging. Daraxonrasib, a KRAS-targeting pill, is in Phase 3 trials after earlier encouraging results and FDA Breakthro...
DiCE Grants — Autumn 2025
DiCE opens Autumn 2025 grants: unrestricted operational support for Full and Associate Members, plus the €5,000 Wolfram Nolte Memorial Award for ...